Search results
Author(s):
Mahmoud Izraiq
,
Nail Alshoubaki
,
Omran A Abu-Dhaim
,
et al
Added:
10 months ago
Author(s):
Mahmoud Izraiq
,
Nail Alshoubaki
,
Omran A Abu-Dhaim
,
et al
Added:
1 year ago
Individualising Antithrombotic Strategies for ACS and CCS
Author(s):
Robert F Storey
Added:
1 year ago
Review Article
AHA 24: The OPTION Trial
Author(s):
Oussama M Wazni
Added:
1 year ago
Video
Author(s):
Josep Rodés-Cabau
Added:
3 months ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device…
View more
Shortened Dual Antiplatelet Therapy
Author(s):
Kevin S Tang
,
Shoujit Banerjee
,
George Tang
,
et al
Added:
2 years ago
Review Article
The Role of Non-invasive Tests in Pulmonary Embolism
Author(s):
Ana Torremocha
,
Daniel Tébar
,
Alfonso Jurado-Román
Added:
4 months ago
Review Article
Author(s):
Mark Anderson
,
Nicolas Brozzi
,
Raul Rosenthal
,
et al
Added:
2 years ago
Author(s):
Luca Testa
Added:
1 year ago
Dr Luca Testa (IRCCS Policlinico San Donato, IT) discusses the results of the XLIMIT Trial at the EuroPCR 2024 congress in Paris, France.In this video interview, Dr Testa explains the technology behind the XLIMUS® drug-eluting stent (Cardionovum®) and its benefits. He also reviews the XLIMIT Trial, detailing the study design, selection criteria and clinical outcomes.Specifically, the 6 to 9…
View more
Outcomes of CTO PCI in a Non-surgical Centre
Author(s):
Thomas R Gilpin
,
Annette Maznyczka
,
Brijesh Anantharam
,
et al
Added:
1 year ago
Original Research